ABT vs ADMT vs RPM Stock Comparison

Abbott Laboratories, Adm Tronics Unlimited and Rpm International Prices as of Nov 5, 2026 Peers: Industry group
1 more company in this comparison (EW) Create a free account to keep reading and compare up to 10 companies.
ABT Abbott Laboratories
$113.58 +15.7% 1M -8.8% 1Y
Market cap
$191.31B
P/E
40.7x
Revenue (TTM)
$48.23B
Div. yield
0.02%
Medical Devices Healthcare
4 wins
RPM Rpm International Inc/De/
$105.33 +7.1% 1M -2.1% 1Y
Market cap
$13.12B
P/E
19.0x
Revenue (TTM)
$7.97B
Div. yield
–
Paints and Coatings Basic Materials
5 wins

Head to Head

11 decided of 12

Rpm International leads on 5 of the 12 questions below (Rpm International 5, Abbott Laboratories 4, Adm Tronics Unlimited 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionABTADMTRPMLeader
Larger companyMarket capitalisation $191.31B $6.93M $13.12B ABT
Cheaper on earningsLower P/E, profitable companies only 40.7x -17.5x 19.0x RPM
Cheaper on forward earningsLower price / next fiscal year consensus EPS 20.0x — 18.9x RPM
Faster revenue growthRevenue growth, trailing twelve months +10.0% -2.2% +6.0% ABT
More profitableNet margin, trailing twelve months 9.7% -12.2% 8.7% ABT
Better return on capitalReturn on invested capital 5.7% -27.1% 12.5% RPM
Less leveragedLower net debt / EBITDA 2.5x -0.9x 1.8x ADMT
Higher dividend yieldTrailing dividend yield 0.02% 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -8.8% 0.0% -2.1% ADMT
Better 5-year returnAnnualised price return, 5 years -1.8%/yr -3.9%/yr +3.2%/yr RPM
Less volatileAnnualised volatility, 1 year 28.3% 188.1% 30.7% ABT
Higher overall scoreMean of the five percentile scores vs peers 55/100 28/100 60/100 RPM

Percentile Scorecard

ABTADMTRPM

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisABTADMTRPM
Valuation 72 #66 of 229 46 #125 of 229 49 #49 of 95
Growth 23 #170 of 221 2 #217 of 221 59 #39 of 93
Profitability 82 #38 of 210 46 #113 of 210 85 #14 of 89
Financial Health 36 #154 of 240 16 #201 of 240 54 #45 of 96
Shareholder Returns 62 #57 of 147 – 54 #35 of 75
Overall 55 28 60
  • ABT ranked among 247 companies in Medical Devices and Diagnostics
  • ADMT ranked among 247 companies in Medical Devices and Diagnostics
  • RPM ranked among 99 companies in Chemicals

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodABTADMTRPMSPY
1 month +15.7%+80.0%+7.1% -5.9%
3 months +5.2%+125.0%-8.9% -4.6%
6 months +30.5%+12.5%+3.9% +0.2%
Year to date -9.3%-10.0%+1.3% +7.5%
1 year -8.8%0.0%-2.1% +8.2%
3 years +19.6%-18.2%+9.5% +68.3%
3 years, per year +6.1%-6.5%+3.1% +19.0%
5 years -8.7%-18.2%+17.3% +56.5%
5 years, per year -1.8%-3.9%+3.2% +9.4%
10 years +190.6%-52.6%+123.5% +251.5%
10 years, per year +11.3%-7.2%+8.4% +13.4%

Risk

MeasureABTADMTRPMSPY
Volatility, 1Y 28.3%188.1%30.7% 13.6%
Downside volatility, 1Y 27.6%353.6%26.8% 14.2%
Beta vs S&P 500, 1Y 0.07-1.640.92 1.00
Return / volatility, 1Y -0.310.00-0.07 0.60
Max drawdown, 5Y -41.6%-80.0%-33.5% -25.4%
From 52-week high -13.0%-25.0%-12.3% -5.9%
52-week high $130.59$0.12$120.17 $779.14
52-week low $82.56$0.03$93.23 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleABTADMTRPM
P/E now vs peer median 41.9xmedian 26.9x -15.4xmedian 26.9x 19.3xmedian 21.2x
P/S now vs peer median 4.1xmedian 2.9x 1.9xmedian 2.9x 1.7xmedian 1.3x
EV/EBITDA now vs peer median 21.2xmedian 17.5x -24.3xmedian 17.5x 13.2xmedian 11.7x
P/FCF now vs peer median 29.1xmedian 26.4x -38.7xmedian 26.4x 19.0xmedian 17.0x
P/B now vs peer median 3.8xmedian 2.3x 10.1xmedian 2.3x 3.9xmedian 1.5x
PEG now vs peer median -14.56median 0.88 0.55median 0.88 1.76median 1.76

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsABTADMTRPM
Revenue $48.23B $3.24M $7.97B
Gross profit $27.46B $1.27M $3.28B
Operating income $6.65B -$288.99K $961.65M
Net income $4.70B -$395.64K $691.27M
Free cash flow $6.76B -$157.02K $705.58M
R&D $3.31B $522.65K –
EPS (diluted) $2.70 $-0.01 $5.42
Cash & equivalents $4.05B $222.62K $312.84M
Total debt $31.16B $448.85K $2.41B
Shares (diluted) 1.74B 67.59M 127.24M
Enterprise value $165.17B $5.83M $11.89B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricABTADMTRPM
P/E 41.9x -15.4x 19.3x
P/FCF 29.1x -38.7x 19.0x
P/Operating cash flow 22.2x -38.7x 14.5x
P/S 4.1x 1.9x 1.7x
P/B 3.8x 10.1x 3.9x
P/Tangible book 6.1x 10.2x 5.0x
EV/EBITDA 21.2x -24.3x 13.2x
EV/EBIT 33.6x -21.8x 16.1x
EV/Revenue 4.6x 1.9x 1.9x
EV/FCF 33.1x -40.2x 22.0x
EV/Operating cash flow 25.2x -40.2x 16.8x
PEG (3Y EPS CAGR) -14.56 0.55 1.76

Growth

14 metrics
MetricABTADMTRPM
Revenue growth (1Y) 10.0% -2.2% 6.0%
Revenue CAGR (3Y) 6.5% -2.7% 2.8%
Gross profit growth (1Y) 12.1% -6.4% 5.5%
Gross profit CAGR (3Y) 7.8% -7.4% 5.0%
Operating income growth (1Y) -13.8% -93.9% 9.0%
Operating income CAGR (3Y) 3.5% -58.3% 5.9%
Net income growth (1Y) -66.4% -485.4% 0.2%
Net income CAGR (3Y) -3.1% -27.7% 10.5%
EPS growth (1Y) -66.1% -485.4% 0.8%
EPS CAGR (3Y) -2.9% -27.7% 11.0%
Operating cash flow growth (1Y) -2.9% -389.0% 22.1%
Operating cash flow CAGR (3Y) 10.6% -84.7% 0.4%
Free cash flow growth (1Y) -2.3% -389.0% 36.7%
Free cash flow CAGR (3Y) 14.6% -84.7% 2.0%

Profitability

14 metrics
MetricABTADMTRPM
Gross margin 56.9% 39.2% 41.2%
EBITDA margin 21.9% -8.0% 14.8%
Operating margin 13.8% -8.9% 12.1%
Pretax margin 13.6% -12.2% 11.4%
Net margin 9.7% -12.2% 8.7%
FCF margin 14.0% -4.8% 8.9%
Operating cash flow margin 18.4% -4.8% 11.6%
Return on equity 9.1% -67.4% 20.4%
Return on assets 4.3% -20.6% 8.3%
Return on invested capital 5.7% -27.1% 12.5%
Return on capital employed 7.2% -41.9% 15.1%
Asset turnover 0.4x 1.7x 1.0x
Cash conversion (OCF / net income) 1.9x 0.4x 1.3x
Stock comp / revenue 1.5% – 0.5%

Financial Health

11 metrics
MetricABTADMTRPM
Debt / assets 28.8% 22.2% 29.2%
Debt / equity 0.6x 0.7x 0.7x
Net debt / EBITDA 2.5x -0.9x 1.8x
Debt / FCF 4.6x -2.9x 3.4x
Liabilities / assets 52.3% 70.2% 57.7%
Equity / assets 47.7% 29.8% 42.3%
Interest coverage 6.7x -8.0x 8.9x
Current ratio 1.5x 1.0x 1.8x
Quick ratio 0.8x 0.7x 1.0x
Cash ratio 0.3x 0.2x 0.2x
Altman Z-score 3.46 -19.20 3.90

Shareholder Returns

7 metrics
MetricABTADMTRPM
Dividend yield 2.2% – 2.1%
Net buyback yield 0.7% – 0.6%
Shareholder yield 2.9% – 2.7%
Payout ratio (earnings) 92.0% – –
Payout ratio (FCF) 64.0% – –
Dividend growth (1Y) 6.9% – –
Dividend CAGR (3Y) 7.4% – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusABTADMTRPM
Forward P/E 20.0xFY2026 – 18.9xFY2026
EPS, next fiscal year $5.69FY2026 – $5.58FY2026
EPS growth, next FY +10.5%FY2026 – +0.9%FY2026
EPS growth, the year after +10.2% – +12.5%
Revenue, next fiscal year $53.00BFY2026 – $7.69BFY2026
Revenue growth, next FY +19.5%FY2026 – -2.1%FY2026
Revenue growth, the year after -2.2% – +8.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersABTADMTRPM
Held by institutions 79.2% – 86.1%
Institutions holding 2,983 – 797
Change in shares held, QoQ +0.3% – +3.8%
Institutions buying 1,261 – 386
Institutions selling 1,379 – 245
Buyers to sellers 0.91 – 1.58

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

ABTADMTRPM
ABT 1.00 -0.05 0.30
ADMT -0.05 1.00 -0.03
RPM 0.30 -0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, ABT, ADMT and RPM?

Abbott Laboratories (ABT) is the largest by market capitalisation: Abbott Laboratories (ABT) $191.31B, Adm Tronics Unlimited (ADMT) $6.93M, Rpm International (RPM) $13.12B.

Which stock is cheaper, ABT, ADMT and RPM?

Rpm International (RPM) trades on the lowest price-to-earnings ratio (Abbott Laboratories (ABT) 40.7x, Adm Tronics Unlimited (ADMT) -17.5x, Rpm International (RPM) 19.0x). On next year's consensus earnings, Rpm International (RPM) is cheapest (Abbott Laboratories (ABT) 20.0x, Rpm International (RPM) 18.9x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Abbott Laboratories (ABT) grew revenue fastest over the trailing twelve months: Abbott Laboratories (ABT) +10.0%, Adm Tronics Unlimited (ADMT) -2.2%, Rpm International (RPM) +6.0%.

Which company is more profitable?

Abbott Laboratories (ABT) has the highest net margin (Abbott Laboratories (ABT) 9.7%, Adm Tronics Unlimited (ADMT) -12.2%, Rpm International (RPM) 8.7%). On return on invested capital, Rpm International (RPM) leads (Abbott Laboratories (ABT) 5.7%, Adm Tronics Unlimited (ADMT) -27.1%, Rpm International (RPM) 12.5%).

Which stock has performed better?

Over the past year Adm Tronics Unlimited (ADMT) returned the most: Abbott Laboratories (ABT) -8.8%, Adm Tronics Unlimited (ADMT) 0.0%, Rpm International (RPM) -2.1%. Over five years, Rpm International (RPM) compounded fastest (Abbott Laboratories (ABT) -1.8%/yr, Adm Tronics Unlimited (ADMT) -3.9%/yr, Rpm International (RPM) +3.2%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Abbott Laboratories (ABT) 0.02%, Adm Tronics Unlimited (ADMT) 0.00%, Rpm International (RPM) 0.00%. Adm Tronics Unlimited (ADMT) and Rpm International (RPM) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Abbott Laboratories (ABT) has been the steadiest (Abbott Laboratories (ABT) 28.3%, Adm Tronics Unlimited (ADMT) 188.1%, Rpm International (RPM) 30.7%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, ABT, ADMT and RPM?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Rpm International (RPM) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.